TRBC1 immunohistochemistry distinguishes cutaneous T-cell lymphoma from inflammatory dermatitis: A retrospective analysis of 39 cases

Sarah E Nocco; Mark D Ewalt; Andrea P Moy; Natasha E Lewis; Menglei Zhu; Cecilia Lezcano; Klaus Busam; Melissa Pulitzer

doi:10.1016/j.jaad.2023.11.051

TRBC1 immunohistochemistry distinguishes cutaneous T-cell lymphoma from inflammatory dermatitis: A retrospective analysis of 39 cases

J Am Acad Dermatol. 2024 Apr;90(4):839-841. doi: 10.1016/j.jaad.2023.11.051. Epub 2023 Dec 6.

Authors

Sarah E Nocco¹, Mark D Ewalt², Andrea P Moy², Natasha E Lewis², Menglei Zhu², Cecilia Lezcano², Klaus Busam², Melissa Pulitzer³

Affiliations

¹ Department of Dermatology, Weill Cornell Medicine, New York, New York.
² Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
³ Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. Electronic address: pulitzem@mskcc.org.

PMID: 38061444
PMCID: PMC10960695 (available on 2025-04-01)
DOI: 10.1016/j.jaad.2023.11.051

No abstract available

Keywords: CTCL; FFPE; TRBC1; cutaneous T-cell lymphoma; flow cytometry lymphoma; formalin-fixed paraffin-embedded; immunohistochemistry; lymphoproliferative disorders.

MeSH terms

Dermatitis* / diagnosis
Dermatitis* / etiology
Humans
Immunohistochemistry
Lymphoma, T-Cell, Cutaneous* / diagnosis
Lymphoma, T-Cell, Cutaneous* / pathology
Retrospective Studies
Skin Neoplasms* / diagnosis
Skin Neoplasms* / pathology

Grants and funding

P30 CA008748/CA/NCI NIH HHS/United States